Safety and efficacy of subcutaneous bolus injection of deferoxamine in adult patients with iron overload: an update.
Franchini
Massimo
M
Gandini
Giorgio
G
Veneri
Dino
D
Aprili
Giuseppe
G
D000368:Aged; D000740:Anemia / Q000097:blood; D003676:Deferoxamine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007502:Iron Chelating Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D019190:Iron Overload / Q000188:drug therapy* / Q000209:etiology; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood; D008228:Lymphoma, Non-Hodgkin / Q000097:blood; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D015203:Reproducibility of Results; D012449:Safety; D016896:Treatment Outcome
D007502:Iron Chelating Agents; D003676:Deferoxamine